Piramal Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 28, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	229,439	181,305	297,962	170,528	81,683	-
Market Cap Growth	-16.70%	-39.15%	74.73%	108.77%	-	-
Enterprise Value	272,631	222,374	341,742	209,922	130,128	-
Last Close Price	172.40	136.45	224.35	128.72	66.74	-
PE Ratio	-	-	326.96	956.95	-	-
PS Ratio	2.59	2.04	3.26	2.09	1.15	-
PB Ratio	2.81	2.22	3.67	2.15	1.21	-
P/TBV Ratio	5.71	4.51	11.28	6.97	3.51	-
P/FCF Ratio	30.09	23.78	130.73	58.30	-	-
P/OCF Ratio	13.88	10.97	33.39	16.98	16.88	-
EV/Sales Ratio	3.07	2.51	3.73	2.57	1.84	-
EV/EBITDA Ratio	27.85	25.42	24.92	18.43	22.58	-
EV/EBIT Ratio	184.73	246.04	54.01	45.62	-	-
EV/FCF Ratio	35.75	29.16	149.94	71.77	-	-
Debt / Equity Ratio	0.70	0.70	0.60	0.60	0.83	0.62
Debt / EBITDA Ratio	6.16	6.16	3.44	4.00	9.21	3.63
Debt / FCF Ratio	7.44	7.44	21.31	16.10	-	-
Net Debt / Equity Ratio	0.53	0.53	0.55	0.53	0.74	0.57
Net Debt / EBITDA Ratio	4.94	4.94	3.24	3.68	8.70	3.47
Net Debt / FCF Ratio	5.66	5.66	19.52	14.34	-10.43	-31.27
Asset Turnover	0.53	0.53	0.59	0.55	0.52	0.57
Inventory Turnover	1.21	1.21	1.58	1.69	1.94	1.87
Quick Ratio	0.74	0.74	0.75	0.61	0.64	0.69
Current Ratio	1.51	1.51	1.54	1.25	1.26	1.34
Return on Equity (ROE)	-4.00%	-4.00%	1.14%	0.24%	-2.77%	6.11%
Return on Assets (ROA)	0.34%	0.34%	2.55%	1.93%	-0.20%	2.96%
Return on Invested Capital (ROIC)	0.73%	0.72%	1.13%	0.38%	-0.40%	4.62%
Return on Capital Employed (ROCE)	0.70%	0.70%	5.30%	4.20%	-0.40%	5.70%
Earnings Yield	-1.42%	-1.80%	0.31%	0.10%	-2.28%	-
FCF Yield	3.32%	4.21%	0.77%	1.71%	-5.89%	-
Dividend Yield	0.08%	-	0.06%	0.08%	-	-
Payout Ratio	-	-	15.88%	-	-	13.30%
Buyback Yield / Dilution	0.43%	0.43%	-3.67%	-7.85%	-0.95%	-87.83%
Total Shareholder Return	0.51%	0.43%	-3.61%	-7.76%	-0.95%	-87.83%